{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Dublin",
      "state": "OH",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA201635"
        ],
        "brand_name": [
          "TROKENDI XR"
        ],
        "generic_name": [
          "TOPIRAMATE"
        ],
        "manufacturer_name": [
          "Supernus Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "17772-101",
          "17772-102",
          "17772-103",
          "17772-104"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "TOPIRAMATE"
        ],
        "rxcui": [
          "1436239",
          "1436245",
          "1437278",
          "1437280",
          "1437283",
          "1437285",
          "1437288",
          "1437290"
        ],
        "spl_id": [
          "4d7bcc14-c816-0b67-e063-6394a90a1097"
        ],
        "spl_set_id": [
          "2dc7957e-a3e5-46bb-aa66-f3250f872f5e"
        ],
        "package_ndc": [
          "17772-102-70",
          "17772-102-01",
          "17772-102-30",
          "17772-102-15",
          "17772-102-10",
          "17772-102-12",
          "17772-102-07",
          "17772-103-70",
          "17772-103-01",
          "17772-103-30",
          "17772-103-15",
          "17772-103-10",
          "17772-103-12",
          "17772-103-07",
          "17772-104-70",
          "17772-104-01",
          "17772-104-30",
          "17772-104-15",
          "17772-104-12",
          "17772-104-10",
          "17772-104-07",
          "17772-101-70",
          "17772-101-01",
          "17772-101-30",
          "17772-101-15",
          "17772-101-10",
          "17772-101-12",
          "17772-101-07"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0317772101300",
          "0317772102307",
          "0317772104301",
          "0317772103304"
        ],
        "nui": [
          "N0000008486",
          "N0000185506",
          "N0000182140"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_moa": [
          "Cytochrome P450 3A4 Inducers [MoA]",
          "Cytochrome P450 2C19 Inhibitors [MoA]"
        ],
        "unii": [
          "0H73WJJ391"
        ]
      },
      "product_type": "Drugs",
      "event_id": "87512",
      "recalling_firm": "Cardinal Health Inc.",
      "address_1": "7000 Cardinal Pl",
      "address_2": "N/A",
      "postal_code": "43017-1091",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "FL, GA, SC",
      "recall_number": "D-0570-2021",
      "product_description": "Trokendi XR (topiramate) extended-release capsules 100 mg 30 Capsules Rx only, Manufactured by: Catalent Pharma Solutions Winchester, KY 40391 USA Manufactured for: Supernus Pharmaceuticals, Inc. Rockville, MD 20850 USA, NDC 17772-103-30",
      "product_quantity": "490 bottles",
      "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.",
      "recall_initiation_date": "20210315",
      "center_classification_date": "20210524",
      "termination_date": "20240617",
      "report_date": "20210602",
      "code_info": "1741214"
    }
  ]
}